California State Teachers Retirement System Purchases 57,544 Shares of Tilray Inc (NASDAQ:TLRY)

California State Teachers Retirement System raised its position in shares of Tilray Inc (NASDAQ:TLRYFree Report) by 8.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 778,513 shares of the company’s stock after acquiring an additional 57,544 shares during the period. California State Teachers Retirement System owned approximately 0.08% of Tilray worth $1,035,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of TLRY. Tidal Investments LLC increased its position in Tilray by 9.2% during the fourth quarter. Tidal Investments LLC now owns 10,595,264 shares of the company’s stock valued at $14,092,000 after acquiring an additional 889,086 shares during the last quarter. Quinn Opportunity Partners LLC increased its position in Tilray by 108.0% during the fourth quarter. Quinn Opportunity Partners LLC now owns 1,618,080 shares of the company’s stock valued at $2,152,000 after acquiring an additional 840,000 shares during the last quarter. Virtu Financial LLC bought a new position in Tilray during the fourth quarter valued at $1,029,000. Dimensional Fund Advisors LP increased its position in Tilray by 54.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company’s stock valued at $2,890,000 after acquiring an additional 769,569 shares during the last quarter. Finally, Millennium Management LLC bought a new position in Tilray during the fourth quarter valued at $879,000. Institutional investors own 9.35% of the company’s stock.

Tilray Trading Up 2.4%

NASDAQ TLRY opened at $0.42 on Wednesday. The company’s 50-day moving average price is $0.46 and its 200-day moving average price is $0.84. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The stock has a market cap of $422.43 million, a PE ratio of -1.40 and a beta of 1.83. Tilray Inc has a 12 month low of $0.37 and a 12 month high of $2.15.

Tilray (NASDAQ:TLRYGet Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The company had revenue of $185.78 million during the quarter, compared to the consensus estimate of $213.38 million. Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. Equities research analysts forecast that Tilray Inc will post -0.2 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on TLRY. Piper Sandler cut their price target on shares of Tilray from $2.00 to $1.00 and set a “neutral” rating on the stock in a report on Wednesday, April 9th. Roth Capital restated a “neutral” rating on shares of Tilray in a report on Monday, April 14th.

Get Our Latest Stock Analysis on TLRY

About Tilray

(Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

See Also

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.